Skip to main content

Table 2 Evidence profiles for selected health outcomes related to intensive vs. standard follow-up in breast cancer patients

From: Intensive follow-up for women with breast cancer: review of clinical, economic and patient’s preference domains through evidence to decision framework

Quality assessment

No. of patients

Effect

Quality

Importance

No. of studies

Study design

Risk of bias

Inconsistency

Indirectness

Imprecision

Other considerations

Intensive follow-up

Non-intensive follow-up

Relative (95% CI)

Absolute (95% CI)

10-year overall mortality in women with breast cancer

1

RCT

not serious

not serious

not serious

not serious

none

222/622 (35.7%)

212/621 (34.1%)

RR 1.05

17 more per 1000

CRITICAL

Palli 1999

(0.90 to 1.22)

(from 34 fewer to 75 more)

HIGH

5-year overall mortality in women with breast cancer

3

RCT

not serious

not serious

not serious

not serious

none

277/1520 (18.2%)

277/1515 (18.3%)

RR 1.00

0 fewer per 1000

CRITICAL

Rosselli del Turco 1994

(0.86 to 1.16)

(from 26 fewer to 29 more)

HIGH

GIVIO 1994

   

Kokko 2003

5-year recurrence of breast cancer

3

RCT

serious1

not serious

not serious

not serious

none

460/1520 (30.3%)

414/1515 (27.3%)

RR 1.08

22 more per 1000

CRITICAL

Rosselli del Turco 1994

(0.89 to 1.30)

(from 30 fewer to 82 more)

MODERATE

GIVIO 1994

   

Kokko 2003

Any time recurrence of breast cancer (follow up: range 1 to 5 years)

5

RCT

serious1

not serious

not serious

not serious

none

475/1609 (29.5%)

427/1608 (26.6%)

RR 1.10

27 more per 1000

CRITICAL

Rosselli del Turco 1994

(0.95 to 1.27)

(from 13 fewer to 72 more)

MODERATE

GIVIO 1994

   

Brown 2002

Kokko 2003

Oltra 2007

Satisfaction of women with the type of follow-up - Reassurance (follow-up: range 1 to 3 years)

2

RCT

serious1

very serious2

not serious

not serious

none

92/127 (72.4%)

72/127 (56.7%)

RR 1.28

159 more per 1000

IMPORTANT

Brown 2002

(1.07 to 1.54)

(from 40 more to 306 more)

VERY LOW

Gulliford 1997

   

Satisfaction of women with the type of follow-up - Convenience (follow-up: mean 1 year)

1

RCT

serious1

not serious

not serious

not serious

none

1/31 (3.2%)

22/30 (73.3%)

RR 0.04

704 fewer per 1000

IMPORTANT

Brown 2002

(0.01 to 0.31)

(from 506 fewer to 726 fewer)

LOW

  1. Legend: Abbreviations: RCT: Randomised clinical trial; CI: Confidence interval; RR: Risk Ratio; HR: Hazard Ratio. Notes: 1The quality of evidence was downgraded because studies were not blinded; 2The quality of evidence was downgraded due to important heterogeneity